With 1.83 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.42 million shares. The 52-week range on CRON shows that it touched its highest point at $3.14 and its lowest point at $1.83 during that stretch. It currently has a 1-year price target of $2.53. Beta for the stock currently stands at 0.91.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRON was down-trending over the past week, with a drop of -5.61%, but this was down by -2.12% over a month. Three-month performance dropped to -9.76% while six-month performance fell -20.94%. The stock lost -17.04% in the past year, while it has lost -8.42% so far this year. A look at the trailing 12-month EPS for CRON yields -0.12 with Next year EPS estimates of 0.00. For the next quarter, that number is 0.00. This implies an EPS growth rate of 116.67% for this year and -100.00% for next year.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRON since 4 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.08540463 being high and -$0.09421229 being low. For CRON, this leads to a yearly average estimate of -$0.09107855. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
